CLDN14 Gene Deafness Autosomal Recessive Type 29 NGS Genetic DNA Test
Introduction
The CLDN14 Gene Deafness Autosomal Recessive Type 29 NGS Genetic DNA Test is a cutting-edge diagnostic tool that helps identify genetic causes of hearing loss. Utilizing Next-Generation Sequencing (NGS) technology, this test provides an in-depth analysis of the CLDN14 gene, which is known to play a critical role in auditory function. Understanding the genetic basis of hearing impairment is vital for appropriate management and treatment options.
What the Test Measures
This test specifically measures variations in the CLDN14 gene that are associated with autosomal recessive hearing loss. By identifying these genetic mutations, healthcare providers can better understand the underlying causes of hearing impairment in individuals.
Who Should Consider This Test?
Individuals who may benefit from the CLDN14 Gene Deafness Test include:
- Those with a family history of hearing loss.
- Individuals experiencing unexplained hearing impairment.
- Patients with symptoms such as difficulty hearing in noisy environments or progressive hearing loss.
- Anyone advised by an ENT specialist or genetic counselor.
Benefits of Taking the Test
Taking the CLDN14 Gene Deafness Test offers numerous benefits:
- Early identification of genetic hearing loss, allowing for timely intervention.
- Informed family planning decisions based on genetic risk factors.
- Access to specialized care and tailored management strategies for hearing impairment.
- Increased understanding of the condition and its implications.
Understanding Your Results
Results from the CLDN14 Gene Deafness Test will provide insights into any detected mutations in the CLDN14 gene. A genetic counselor or an ENT specialist will help interpret these results, outlining the implications for the individual and their family.
Test Pricing
| Discount Price | Regular Price |
|---|---|
| 40,000 KSh | 56,000 KSh |
Sample Type and Turnaround Time
The test can be conducted using:
- Blood
- Extracted DNA
- One drop of blood on an FTA card
The turnaround time for results is approximately 3 to 4 weeks.
Booking Your Test
We have branches across all major cities in Kenya, making it convenient for you to access our services. To book the CLDN14 Gene Deafness Autosomal Recessive Type 29 NGS Genetic DNA Test, please call or WhatsApp us at +254713408028. Don’t miss the opportunity to gain valuable insights into your hearing health!
